(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 0.49% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.89%.
Avanos Medical's revenue in 2025 is $692,500,000.On average, 1 Wall Street analysts forecast AVNS's revenue for 2025 to be $31,784,771,435, with the lowest AVNS revenue forecast at $31,784,771,435, and the highest AVNS revenue forecast at $31,784,771,435. On average, 1 Wall Street analysts forecast AVNS's revenue for 2026 to be $32,333,248,761, with the lowest AVNS revenue forecast at $32,333,248,761, and the highest AVNS revenue forecast at $32,333,248,761.
In 2027, AVNS is forecast to generate $33,236,705,066 in revenue, with the lowest revenue forecast at $33,236,705,066 and the highest revenue forecast at $33,236,705,066.